Trump Administration Puts Freeze on Release of Health Info From Government Agencies
Medically reviewed by Drugs.com.
By Stephanie Brown HealthDay Reporter
FRIDAY, Jan. 24, 2025 -- President Donald Trump's administration has placed a freeze on information being released from government health agencies.
According to a memo obtained by the Associated Press, the "immediate pause" applies to information released as regulations, guidance, announcements, press releases, social media posts, and website posts because the newly elected administration wants all such information to be reviewed by one of their appointees.
The freeze also affects anything intended to be published in the Federal Register, where the executive branch communicates rules and regulations, as well as the Morbidity and Mortality Weekly Report, a U.S. Centers for Disease Control and Prevention scientific publication.
Acting Secretary of the U.S. Department of Health and Human Services Dorothy Fink told agency staff leaders in the memo that the pause is expected to be in effect through Feb. 1, 2025, and agencies subject to the directive include the CDC, National Institutes of Health, and U.S. Food and Drug Administration. Fink added that some exceptions would be made for communications affecting "critical health, safety, environmental, financial, or national security functions."
A former HHS official said Wednesday it is not unusual for incoming administrations to pause agency communications for review; however, it is usually handled by the president's transition team and information flow is running smoothly by inauguration day.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-25 06:00
Read more
- Risk for All-Cause Mortality Lower With High Muscle Strength, Fitness in Cancer
- Why Sparkling Water May (Or May Not) Help You Lose Weight
- Ketamine Use Is on the Rise in U.S.
- Estrogen May Trigger Binge Drinking, Prelim Study Suggests
- CPR Coach Training Boosts Coach Presence on Code Teams in Pediatric ICU
- So, Who Benefits From New Cancer Drugs?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions